innovation.org
Home | About Us | Site Map | Contact Us Search
Impact of Innovation Future of Innovation Stories of Innovation Inside Drug Discovery News Center Tools & Resources
Tools & Resources
New Medicines in Development
Personalized Medicine in Action
Partnership for Prescription Assistance
Sign Up for
our Newsletter:

Get our newsletter on the impact of new medicines and updates on what's new in innovation.

What Others are Saying

The Value of Medicines: What Others are Saying

"Over the last century, the value of gains in life expectancy seen in the U.S. is greater than the total value of all the measured growth in our economic output. New drugs are no small part of this medical miracle. The reduction in U.S. mortality from cardiovascular disease alone has been valued at $1.5 trillion annually from 1970 to 1990."
- Mark McClellan, former FDA Commissioner and current CMS Administrator, speaking before the First International Colloquium on Generic Medicine, September 25, 2003.

"The share of drugs in future medical spending is likely to increase sharply. But even without full cures, drugs that greatly delay the onset and severity of major diseases will reduce expensive and unproductive time spent in hospitals, nursing homes, and under the care of family members...New drugs have the potential to cut the growth of medical spending sharply. It is crucial to take much better advantage of this potential."
- Gary S. Becker, University of Chicago Professor and 1992 Nobel laureate, in March 22, 2004 article in Business Week

"High-price new drugs may be the cheapest weapon we have in our ongoing struggle against rising overall medical expenses."
- JD Kleinke, "The Price of Progress: Prescription Drugs in the Health Care Market," Health Affairs, 20 (2001): 5, 43-60

"If they [mental health patients] don't get the drugs, you end up paying even more because they end up in psychiatric institutions and hospitals. It ends up costing the system much, much more."
- Alina Salganicoff, Vice President of Kaiser Family Foundation, quoted in San Francisco Chronicle, December 17, 2003

"Early and aggressive treatment of diabetes may delay or even prevent many of the complications associated with diabetes, leading to improved quality of life and reduced expenditures in patients with type 2 diabetes."
- Terrance Killiea, "Long-term consequences of Type 2 Diabetes Mellitus," The American Journal of Managed Care 8 (October 2002)

"From Killer to Chronic Disease: Drugs Redefine Cancer for Many"
- Headline of Washington Post story, January 29, 2003, which noted that thanks to advances in care, cancer has evolved into a "chronic disease, much like asthma, diabetes, and, more recently, AIDS."

"The death rate [for heart attacks] is so low now that we're no longer able to track it."
- Dr. Teri Amolio, quoted in a story in The New York Times, January 19, 2003